Is Editas Medicine, Inc. (EDIT) a Buy, Sell, or Hold?
Editas Medicine, Inc.
NASDAQ:EDIT
$3.17 USD
$0.01 (0.32%)
- Volume
- 9.25K
- Average Volume
- 2.52M
- Market Capitalization
- $310.34M
- P/E Ratio
- -2.58
- Dividend Yield
- 0.00%
- Price Target
- $5.00
- Year High
- $4.54
- Year Low
- $1.66
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.22
Analyst Rating
Strong Sell
1 Rating Score
UPSIDE/DOWNSIDE
-36.6% DOWNSIDE
$5.00 Price Target
UPSIDE/DOWNSIDE HIGH
-47.2% DOWNSIDE
$6.00 Price Target High
UPSIDE/DOWNSIDE LOW
-20.8% DOWNSIDE
$4.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Barclays | Gena Wang | $5 | $3.12 | 2024-11-05 05:23 AM | 60.3% |
| Wells Fargo | Yanan Zhu | $9 | $3.29 | 2024-10-23 02:36 AM | 173.6% |
| Robert W. Baird | Joel Beatty | $10 | $3.29 | 2024-10-22 09:41 AM | 204.0% |
| Truist Financial | Joon Lee | $12 | $4.24 | 2024-08-08 03:24 AM | 183.0% |
| Bank of America Securities | Greg Harrison | $15 | $4.205 | 2024-08-08 02:44 AM | 256.7% |
| Evercore ISI | Liisa Bayko | $7 | $5.1 | 2024-05-30 02:02 AM | 37.3% |
| Morgan Stanley | Matthew Harrison | $7 | $5.035 | 2024-05-08 08:34 PM | 39.0% |
| Stifel Nicolaus | Dae Gon Ha | $17 | $6.92 | 2023-09-28 12:38 PM | 145.7% |